Melanoma Research Today is a free monthly online journal that collates and summarizes the latest research about Melanoma, including details on identification, causes, prevention, treatment.

Volume 4 (2007), Issue 6 (June)

1. Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility.
   Oncogene, 26(26): 3846-56. [Abstract] [Full-text]
2. Nuclear survivin is associated with disease recurrence and poor survival in patients with cutaneous malignant melanoma.
   Histopathology, 50(7): 835-42. [Abstract] [Full-text]
3. The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition.
   J Biol Chem, 282(23): 17259-71. [Abstract] [Full-text]
4. Proline prodrug of melphalan targeted to prolidase, a prodrug activating enzyme overexpressed in melanoma.
   Pharm Res, 24(7): 1290-8. [Abstract] [Full-text]
5. What is a sentinel node? Re-evaluating the 10% rule for sentinel lymph node biopsy in melanoma.
   J Surg Oncol, 95(8): 623-8. [Abstract] [Full-text]
6. Estimating choroidal melanoma volume: comparison of methods.
   Ophthalmology, 114(6): 1212-4. [Abstract] [Full-text]
7. High affinity interaction of integrin alpha4beta1 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) enhances migration of human melanoma cells across activated endothelial cell layers.
   J Cell Physiol, 212(2): 368-74. [Abstract] [Full-text]
8. Methylselenol generated from selenomethionine by methioninase downregulates integrin expression and induces caspase-mediated apoptosis of B16F10 melanoma cells.
   J Cell Physiol, 212(2): 386-400. [Abstract] [Full-text]
9. In vivo culture of encapsulated endostatin-secreting Chinese hamster ovary cells for systemic tumor inhibition.
   Hum Gene Ther, 18(5): 474-81. [Abstract] [Full-text]
10. A phase II study of ABT-510 (thrombospondin-1 analog) for the treatment of metastatic melanoma.
    Am J Clin Oncol, 30(3): 303-9. [Abstract] [Full-text]
11. Mechanism of the melanogenesis stimulation activity of (-)-cubebin in murine B16 melanoma cells.
    Bioorg Med Chem, 15(14): 4897-902. [Abstract] [Full-text]
12. Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study.
    Eye, 21(6): 752-9. [Abstract] [Full-text]
13. Surgical therapy of cutaneous melanoma.
    Semin Oncol, 34(3): 270-80. [Abstract] [Full-text]
14. Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy.
    Surgery, 141(6): 728-35. [Abstract] [Full-text]
15. Cost effectiveness of adjuvant interferon in node-positive melanoma.
    J Clin Oncol, 25(17): 2442-8. [Abstract] [Full-text]
16. New founder germline mutations of CDKN2A in melanoma-prone families and multiple primary melanoma development in a patient receiving levodopa treatment.
    Genes Chromosomes Cancer, 46(8): 751-60. [Abstract] [Full-text]
17. Imiquimod enhances the systemic immunity attained by local cryosurgery destruction of melanoma lesions.
    J Invest Dermatol, 127(7): 1673-80. [Abstract] [Full-text]
18. Lubrol-RAFTs in melanoma cells: a molecular platform for tumor-promoting ephrin-B2-integrin-beta1 interaction.
    J Invest Dermatol, 127(7): 1615-21. [Abstract] [Full-text]
19. Functional implication of BMP4 expression on angiogenesis in malignant melanoma.
    Oncogene, 26(28): 4158-70. [Abstract] [Full-text]
20. Treatment parameters modulating regression of human melanoma xenografts by an antibody-drug conjugate (CR011-vcMMAE) targeting GPNMB.
    Cancer Chemother Pharmacol, 60(3): 423-35. [Abstract] [Full-text]
21. Risk factors for presumptive melanoma in skin cancer screening: American Academy of Dermatology National Melanoma/Skin Cancer Screening Program experience 2001-2005.
    J Am Acad Dermatol, 57(1): 60-6. [Abstract] [Full-text]
22. Diving into the blue: in vivo microscopic characterization of the dermoscopic blue hue.
    J Am Acad Dermatol, 57(1): 96-104. [Abstract] [Full-text]
23. Clinical significance of the RT-PCR positive sentinel node in melanoma.
    J Surg Oncol, 95(7): 546-54. [Abstract] [Full-text]
24. Melanoma induces immunosuppression by up-regulating FOXP3(+) regulatory T cells.
    J Surg Res, 141(1): 72-7. [Abstract] [Full-text]
25. Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine.
    J Clin Oncol, 25(18): 2546-53. [Abstract] [Full-text]
26. Randomized trial of the combination of lomeguatrib and temozolomide compared with temozolomide alone in chemotherapy naive patients with metastatic cutaneous melanoma.
    J Clin Oncol, 25(18): 2540-5. [Abstract] [Full-text]
27. Differentiating spitzoid melanomas from Spitz nevi through CD99 expression.
    J Cutan Pathol, 34(7): 576-80. [Abstract] [Full-text]
28. Expression of dicarbonyl/L-xylulose reductase (DCXR) in human skin and melanocytic lesions: morphological studies supporting cell adhesion function of DCXR.
    J Cutan Pathol, 34(7): 535-42. [Abstract] [Full-text]
29. Presence and phenotype of dendritic cells in uveal melanoma.
    Br J Ophthalmol, 91(7): 971-6. [Abstract] [Full-text]
30. Finger's "slotted" eye plaque for radiation therapy: treatment of juxtapapillary and circumpapillary intraocular tumours.
    Br J Ophthalmol, 91(7): 891-4. [Abstract] [Full-text]
31. Ciliary body melanoma with limited nodular extrascleral extension and diffuse iris-angle infiltration treated by whole anterior segment plaque radiotherapy.
    Int Ophthalmol, 27(4): 273-6. [Abstract] [Full-text]
32. Interleukin 21 therapy increases the density of tumor infiltrating CD8+ T cells and inhibits the growth of syngeneic tumors.
    Cancer Immunol Immunother, 56(9): 1417-28. [Abstract] [Full-text]
33. Density of DC-LAMP(+) mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor.
    Cancer Immunol Immunother, 56(9): 1459-69. [Abstract] [Full-text]

© 2004-2008 Melanoma Research Today. All Rights Reserved.